Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -57.78M
March 31, 2026 -65.72M
December 31, 2025 -14.08M
September 30, 2025 -35.41M
June 30, 2025 -60.44M
March 31, 2025 -74.83M
December 31, 2024 -64.51M
September 30, 2024 -51.06M
June 30, 2024 -94.00M
March 31, 2024 -30.28M
December 31, 2023 -78.73M
September 30, 2023 -77.79M
June 30, 2023 -94.02M
March 31, 2023 -74.44M
December 31, 2022 -90.75M
September 30, 2022 -78.16M
Date Value
June 30, 2022 -111.94M
March 31, 2022 -28.62M
December 31, 2021 -76.99M
September 30, 2021 -53.14M
June 30, 2021 -62.59M
March 31, 2021 -16.29M
December 31, 2020 -59.22M
September 30, 2020 -8.057M
June 30, 2020 -23.36M
March 31, 2020 -13.28M
December 31, 2019 -30.34M
September 30, 2019 1.347M
June 30, 2019 -13.84M
March 31, 2019 -4.303M
December 31, 2018 -26.54M
September 30, 2018 -22.05M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Natera, Inc. 54.79M
NeoGenomics, Inc. 19.96M
Quest Diagnostics, Inc. 597.00M
Labcorp Holdings, Inc. 445.50M
OPKO Health, Inc. -43.50M